Top

Reactions Weekly

Published in:

01-01-2023 | Sinus Surgery | Case report

Omalizumab

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Matsumoto-Sasaki M, et al. [A CASE OF SEVERE ASTHMA RESULTING IN DISEASE EXACERBATION AFTER PROLONGATION OF THE DOSING INTERVAL AFTER LONG-TERM OMALIZUMAB ADMINISTRATION]. [Japanese]. Arerugi 71: 944-948, No. 8, Jan 2022. Available from: URL: http://doi.org/10.15036/arerugi.71.944 [Japanese; summarised from a translation]

Title: Omalizumab
Lack of efficacy: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Sinus Surgery
Omalizumab
Bronchial Asthma
Theophylline
Dupilumab
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31177-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Omalizumab

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Immunosuppressants

Quetiapine

Ketamine

Epoprostenol

Immune-globulin